Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing

被引：11

作者：

Chen, Carol X. -Q. ^{[1
]}

You, Zhipeng ^{[1
]}

Abdian, Narges ^{[1
]}

Sirois, Julien ^{[1
]}

Shlaifer, Irina ^{[1
]}

Tabatabaei, Mahdieh ^{[2
]}

Boivin, Marie-Noelle ^{[2
]}

Gaborieau, Lydiane ^{[2
]}

Karamchandani, Jason ^{[2
]}

Beitel, Lenore K. ^{[1
]}

Fon, Edward A. ^{[3
,4
]}

Durcan, Thomas M. ^{[1
]}

机构：

[1] McGill Univ, Neuros Early Drug Discovery Unit EDDU, 3801 Univ St, Montreal, PQ H3A 2B4, Canada

[2] McGill Univ, C BIG Repository C BIG, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada

[3] Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada

[4] Montreal Neurol Inst, Dept Neurol & Neurosurg, Neurodegenerat Dis Grp, Montreal, PQ H3A 2B4, Canada

来源：

STEM CELL RESEARCH | 2022年 / 62卷

关键词：

D O I：

10.1016/j.scr.2022.102806

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Autosomal recessive mutations in either PRKN or PINK1 are associated with early-onset Parkinson's disease. The corresponding proteins, PRKN, an E3 ubiquitin ligase, and the mitochondrial serine/threonine-protein kinase PINK1 play a role in mitochondrial quality control. Using CRISPR/CAS9 technology we generated three human iPSC lines from the well characterized AIW002-02 control line. These isogenic iPSCs contain homozygous knockouts of PRKN (PRKN-KO, CBIGi001-A-1), PINK1 (PINK1-KO, CBIGi001-A-2) or both PINK1 and PRKN (PINK1-KO/PRKN-KO, CBIGi001-A-3). The knockout lines display normal karyotypes, express pluripotency markers and upon differentiation into relevant brain cells or midbrain organoids may be valuable tools to model Parkinson's disease.

引用

页数：7

共 5 条

[1]

Chen C.-Q., 2019, ZENODO, DOI 10.5281/zenodo.3738323

[2] A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types [J].

Chen, Carol X-Q ;

Abdian, Narges ;

Maussion, Gilles ;

Thomas, Rhalena A. ;

Demirova, Iveta ;

Cai, Eddie ;

Tabatabaei, Mahdieh ;

Beitel, Lenore K. ;

Karamchandani, Jason ;

Fon, Edward A. ;

Durcan, Thomas M. .

METHODS AND PROTOCOLS, 2021, 4 (03)

[3] A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis [J].

Deneault, Eric ;

Chaineau, Mathilde ;

Nicouleau, Michael ;

Montiel, Maria Jose Castellanos ;

Flores, Anna Kristyna Franco ;

Haghi, Ghazal ;

Chen, Carol X-Q ;

Abdian, Narges ;

Shlaifer, Irina ;

Beitel, Lenore K. ;

Durcan, Thomas M. .

METHODS, 2022, 203 :297-310

[4] The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications [J].

Durcan, Thomas M. ;

Fon, Edward A. .

GENES & DEVELOPMENT, 2015, 29 (10) :989-999

[5] Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes [J].

Sison, S. L. ;

Vermilyea, S. C. ;

Emborg, M. E. ;

Ebert, A. D. .

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (12)

← 1 →